Trial Profile

Study of the Effect of Chondroitin Sulfate(CONDROSAN) on Structural Changes in Knee Osteoarthritis Patients Assessed by MRI

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 07 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Chondroitin sulfate (Primary) ; Celecoxib
Indications Osteoarthritis
Focus Registrational; Therapeutic Use
Acronyms MOSAIC
Sponsors Bioiberica

Most Recent Events

14 Jun 2017 According to a Bioiberica media release, results from this and the CONCEPT trial will be presented at the 2017 Annual European Congress of Rheumatology.
09 Jan 2017 Primary endpoint (Cartilage Volume Loss of the Lateral Compartment) has been met, according to a Bioiberica media release.
09 Jan 2017 According to a Bioiberica media release, results from the study were published in the Arthritis Research and Therapy journal.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com